The Institute of Cancer Research, London, is one of the world’s most influential cancer research organisations. Today, find out how 'basic research' helps find new treatments, watch us work to understand secondary breast cancer, and sign up to the Berlin Marathon.
Scientists have pioneered the use of a high-powered imaging technique to picture in exquisite detail one of the central proteins of life – a cellular recycling unit with a role in many diseases.
In the first of five articles short-listed for the ICR's Mel Greaves Science Writing Prize 2015, the winner Dr Hugh Harvey writes about re-inventing an age-old test for prostate cancer.
Professor Andrew Tutt talks about the LEGACY study – which aims to better understand the underlying biology of breast cancer that has spread to other parts of the body.
Scientists at the ICR have identified a gene mutation linked to the development of an aggressive form of brain cancer.
Pioneering phase I studies of new cancer drugs
Developing new drugs for hard-to-treat childhood cancers
Genome analysis at our Tumour Profiling Unit – discovering cancer’s weaknesses
Personalising treatments for patients on clinical trials
How mouse 'avatars' could help tailor cancer treatments in head and neck cancers
Join #teamICR in Berlin for a marathon party on the fastest course in the world. Achieve your personal best on this fast, flat course.
Our Chief Executive and President, Professor Paul Workman, shares his experiences on his blog, The Drug Discoverer.
The ICR’s research aims to learn more about cancer genetics and tumour biology – and use that information in discovering new treatments.
Our PhD students conduct world-class research projects, while our MSc in Clinical Oncology teaches about the latest in clinical practice.
We work in close partnership with industry to take results into the clinic as soon as possible, and make sure our research delivers for cancer patients.
The ICR is the top-ranked academic research centre in the UK after coming first overall in the 2014 Research Excellence Framework.
Structural biology – mapping the intricate configuration of proteins – provides a classic example of the benefits of basic research
How we're fighting neuroblastoma
Why ‘basic research’ is critical for understanding and treating cancer
#InTheNews Removing protein in the blood could halt the growth of breast cancer http://t.co/7GHefZ2Qm0 @MailOnline http://t.co/zQ5hyYYPjU